These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
515 related articles for article (PubMed ID: 18647310)
1. Pimecrolimus cream 1% in erosive oral lichen planus--a prospective randomized double-blind vehicle-controlled study. Volz T; Caroli U; Lüdtke H; Bräutigam M; Kohler-Späth H; Röcken M; Biedermann T Br J Dermatol; 2008 Sep; 159(4):936-41. PubMed ID: 18647310 [TBL] [Abstract][Full Text] [Related]
2. Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood. Passeron T; Lacour JP; Fontas E; Ortonne JP Arch Dermatol; 2007 Apr; 143(4):472-6. PubMed ID: 17438179 [TBL] [Abstract][Full Text] [Related]
3. Pimecrolimus 1% cream for oral erosive lichen planus: a 6-week randomized, double-blind, vehicle-controlled study with a 6-week open-label extension to assess efficacy and safety. McCaughey C; Machan M; Bennett R; Zone JJ; Hull CM J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1061-7. PubMed ID: 21175873 [TBL] [Abstract][Full Text] [Related]
4. Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus. Gorouhi F; Solhpour A; Beitollahi JM; Afshar S; Davari P; Hashemi P; Nassiri Kashani M; Firooz A J Am Acad Dermatol; 2007 Nov; 57(5):806-13. PubMed ID: 17658663 [TBL] [Abstract][Full Text] [Related]
5. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis. Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179 [TBL] [Abstract][Full Text] [Related]
6. Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series. Lonsdale-Eccles AA; Velangi S Br J Dermatol; 2005 Aug; 153(2):390-4. PubMed ID: 16086755 [TBL] [Abstract][Full Text] [Related]
7. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea. Karabulut AA; Izol Serel B; Eksioglu HM J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059 [TBL] [Abstract][Full Text] [Related]
8. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study. Gribetz C; Ling M; Lebwohl M; Pariser D; Draelos Z; Gottlieb AB; Zaias N; Chen DM; Parneix-Spake A; Hultsch T; Menter A J Am Acad Dermatol; 2004 Nov; 51(5):731-8. PubMed ID: 15523351 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study. Dawid M; Veensalu M; Grassberger M; Wolff K J Dtsch Dermatol Ges; 2006 Nov; 4(11):942-6. PubMed ID: 17081269 [TBL] [Abstract][Full Text] [Related]
10. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial. Weissenbacher S; Merkl J; Hildebrandt B; Wollenberg A; Braeutigam M; Ring J; Hofmann H Br J Dermatol; 2007 Apr; 156(4):728-32. PubMed ID: 17493072 [TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids. Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515 [TBL] [Abstract][Full Text] [Related]
12. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780 [TBL] [Abstract][Full Text] [Related]
13. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial. Gollnick H; Kaufmann R; Stough D; Heikkila H; Andriano K; Grinienko A; Jimenez P; Br J Dermatol; 2008 May; 158(5):1083-93. PubMed ID: 18341665 [TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis. Schwarz T; Kreiselmaier I; Bieber T; Thaci D; Simon JC; Meurer M; Werfel T; Zuberbier T; Luger TA; Wollenberg A; Bräutigam M J Am Acad Dermatol; 2008 Jul; 59(1):34-40. PubMed ID: 18462835 [TBL] [Abstract][Full Text] [Related]
15. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis. Hebert AA Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454 [TBL] [Abstract][Full Text] [Related]
16. Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease. Zuberbier T; Bräutigam M J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):718-21. PubMed ID: 18312323 [TBL] [Abstract][Full Text] [Related]
17. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial. Leung DY; Hanifin JM; Pariser DM; Barber KA; Langley RG; Schlievert PM; Abrams B; Hultsch T Br J Dermatol; 2009 Aug; 161(2):435-43. PubMed ID: 19416245 [TBL] [Abstract][Full Text] [Related]
18. Pimecrolimus cream (1%) efficacy in perioral dermatitis - results of a randomized, double-blind, vehicle-controlled study in 40 patients. Oppel T; Pavicic T; Kamann S; Bräutigam M; Wollenberg A J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1175-80. PubMed ID: 17894701 [TBL] [Abstract][Full Text] [Related]